{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:28:11Z","timestamp":1793046491735,"version":"4.5.0"},"reference-count":40,"publisher":"The Pediatric Pharmacy Association","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVES<\/jats:title>\n                    <jats:p>The purpose of this study was to describe overall screening, prevention, and treatments for pediatric delirium at various neonatal intensive care units (NICUs), cardiac intensive care units (CICUs), and pediatric intensive care units (PICUs) from the Pediatric Pharmacy Association (PPA) membership. The primary objective was to identify the number of respondents that had a defined delirium-based protocol. The secondary objectives included identification of delirium assessment tools used, first- and second-line delirium treatment options, and monitoring practices for antipsychotics for delirium management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>A cross-sectional questionnaire was distributed to PPA members from February 8, 2022, to March, 25, 2022. Comparisons between the NICUs, PICUs, and CICUs were conducted by using chi-square tests, with a priori p value of &amp;lt;0.05<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>The questionnaire was completed by 84 respondents at 62 institutions; respondents practiced in the PICU or mixed PICU (n = 48; 57.1%), CICU (n = 13; 15.5%), and NICU (n = 23; 27.4%). Sixty-one respondents (72.6%) noted their units routinely screen for delirium, and there was a significant difference between the respondents of different units that use a delirium scoring tool (p &amp;lt; 0.01). Only 33 respondents (39.3%) had a defined delirium protocol, and there was no difference between units (p = 0.31). The most common agents used for delirium treatment were quetiapine and risperidone. There was variability in the monitoring used between respondents, but the majority (n = 74; 88%) monitor electrocardiograms to assess the corrected QT interval, but practice variability existed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>Most respondents did not have a defined delirium protocol. Variations were noted in the treatment options and monitoring for critically ill pediatric patients with delirium.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5863\/1551-6776-28.6.540","type":"journal-article","created":{"date-parts":[[2023,10,30]],"date-time":"2023-10-30T19:54:52Z","timestamp":1698695692000},"page":"540-552","source":"Crossref","is-referenced-by-count":6,"title":["Delirium Assessment Treatment Strategies in Critically Ill Pediatric Patients: A Pediatric Pharmacy Association Practice-Based Research Network Survey Study"],"prefix":"10.5863","volume":"28","author":[{"given":"Caitlyn V.","family":"Bradford","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice (CVB), Philadelphia College of Pharmacy, Saint Joseph\u2019s University, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mon-Yee","family":"Fung","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (M-YF), University of Michigan MOTT Children\u2019s Hospital, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (AW), Children\u2019s National Hospital, Washington, DC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily C.","family":"Benefield","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (ECB), Seattle Children\u2019s Hospital, Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferras","family":"Bashqoy","sequence":"additional","affiliation":[{"name":"Department of Pharmacy (FB), Hassenfeld Children\u2019s Hospital at NYU Langone Health, New York City, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Neely","sequence":"additional","affiliation":[{"name":"Department of Pharmacy: Clinical and Administrative Sciences (SBN, PNJ), College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter N.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Pharmacy: Clinical and Administrative Sciences (SBN, PNJ), College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3883","published-online":{"date-parts":[[2023,10,28]]},"reference":[{"issue":"(21)","key":"2023111414185288400_i2331-348X-28-6-540-b1","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.1001\/jama.286.21.2703","article-title":"Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU)","volume":"286","author":"Ely","year":"2001","journal-title":"JAMA"},{"issue":"(4)","key":"2023111414185288400_i2331-348X-28-6-540-b2","doi-asserted-by":"crossref","first-page":"58","DOI":"10.5498\/wjp.v2.i4.58","article-title":"Assessment scales for delirium: a review","volume":"2","author":"Grover","year":"2012","journal-title":"World J Psychiatry"},{"issue":"(1)","key":"2023111414185288400_i2331-348X-28-6-540-b3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0165-1781(88)90037-6","article-title":"A symptom rating scale for delirium","volume":"23","author":"Trzepacz","year":"1988","journal-title":"Psychiatry Res"},{"issue":"(3)","key":"2023111414185288400_i2331-348X-28-6-540-b4","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/CCM.0000000000001428","article-title":"The Preschool Confusion Assessment Method for the ICU: valid and reliable delirium monitoring for critically ill infants and children","volume":"44","author":"Smith","year":"2016","journal-title":"Crit Care Med"},{"issue":"(1)","key":"2023111414185288400_i2331-348X-28-6-540-b5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/CCM.0b013e3181feb489","article-title":"Diagnosing delirium in critically ill children: validity and reliability of the Pediatric Confusion Assessment Method for the Intensive Care Unit","volume":"39","author":"Smith","year":"2011","journal-title":"Crit Care Med"},{"issue":"(3)","key":"2023111414185288400_i2331-348X-28-6-540-b6","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/CCM.0b013e3182a66b76","article-title":"Cornell Assessment of Pediatric Delirium: a valid, rapid, observational tool for screening delirium in the PICU","volume":"42","author":"Traube","year":"2014","journal-title":"Crit Care Med"},{"issue":"(5)","key":"2023111414185288400_i2331-348X-28-6-540-b7","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.pcl.2017.06.009","article-title":"Delirium in pediatric critical care","volume":"64","author":"Patel","year":"2017","journal-title":"Pediatr Clin N Am"},{"issue":"(6)","key":"2023111414185288400_i2331-348X-28-6-540-b8","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s00134-016-4344-1","article-title":"Clinical recommendations for pain, sedation, withdrawal and delirium assessment in critically ill infants and children: an ESPNIC position statement for healthcare professionals","volume":"42","author":"Harris","year":"2016","journal-title":"Intensive Care Med"},{"issue":"(2)","key":"2023111414185288400_i2331-348X-28-6-540-b9","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1097\/PCC.0000000000002873","article-title":"Society of Critical Care Medicine Clinical practice guidelines on prevention and management of pain, agitation, neuromuscular blockade, and delirium in critically ill pediatric patients with consideration of the ICU environment and early mobility","volume":"23","author":"Smith","year":"2022","journal-title":"Pediatric Crit Care Med"},{"issue":"(2)","key":"2023111414185288400_i2331-348X-28-6-540-b10","first-page":"81","article-title":"Antipsychotic use in the prevention and treatment of intensive care unit delirium in pediatric patients","volume":"25","author":"Capino","year":"2020","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"(4)","key":"2023111414185288400_i2331-348X-28-6-540-b11","first-page":"271","article-title":"Practice variability in screening and treating pediatric critical illness delirium: survey","volume":"10","author":"Aljabari","year":"2020","journal-title":"J Pediatr Intensive Care"},{"issue":"(7)","key":"2023111414185288400_i2331-348X-28-6-540-b12","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1097\/CCM.0000000000000326","article-title":"Sedation, sleep promotion, and delirium screening practices in the care of mechanically ventilated children: a wake-up call for the pediatric critical care community","volume":"42","author":"Kudchadkar","year":"2014","journal-title":"Crit Care Med"},{"issue":"(5)","key":"2023111414185288400_i2331-348X-28-6-540-b13","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/ped.14139","article-title":"Survey of analgesia and sedation in pediatric intensive care units in Japan","volume":"62","author":"Koizumi","year":"2020","journal-title":"Pediatr Int"},{"issue":"(9)","key":"2023111414185288400_i2331-348X-28-6-540-b14","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/PCC.0000000000000864","article-title":"Survey of sedation and analgesia practice among Canadian pediatric critical care physicians","volume":"17","author":"Guerra","year":"2016","journal-title":"Pediatr Crit Care Med"},{"key":"2023111414185288400_i2331-348X-28-6-540-b15","doi-asserted-by":"crossref","first-page":"eAO5168","DOI":"10.31744\/einstein_journal\/2020AO5168","article-title":"Practices related to assessment of sedation, analgesia, and delirium among critical care pediatricians in Brazil","volume":"18","author":"Junior","year":"2020","journal-title":"Einstein (Sao Paulo)."},{"issue":"(9)","key":"2023111414185288400_i2331-348X-28-6-540-b16","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1097\/CCM.0000000000003194","article-title":"Benzodiazepines and development of delirium in critically ill children: estimating the causal effect","volume":"46","author":"Mody","year":"2018","journal-title":"Crit Care Med"},{"issue":"(10)","key":"2023111414185288400_i2331-348X-28-6-540-b17","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1097\/PCC.0000000000001658","article-title":"Anticholinergic medication burden in pediatric prolonged critical illness: a potentially modifiable risk factor for delirium","volume":"19","author":"Madden","year":"2018","journal-title":"Pediatr Crit Care Med"},{"issue":"(5)","key":"2023111414185288400_i2331-348X-28-6-540-b18","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1097\/CCM.0000000000002324","article-title":"Delirium and mortality in critically ill children: epidemiology and outcomes of pediatric delirium","volume":"45","author":"Traube","year":"2017","journal-title":"Crit Care Med"},{"issue":"(4)","key":"2023111414185288400_i2331-348X-28-6-540-b19","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/CCM.0000000000002250","article-title":"Delirium in critically ill children: an international point prevalence study","volume":"45","author":"Traube","year":"2017","journal-title":"Crit Care Med"},{"key":"2023111414185288400_i2331-348X-28-6-540-b20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jclinane.2019.06.027","article-title":"The effect of melatonin on delirium in hospitalized patients: a systematic review and meta-analyses with trial sequential analysis","volume":"59","author":"Ng","year":"2019","journal-title":"J Clin Anesth"},{"issue":"(4)","key":"2023111414185288400_i2331-348X-28-6-540-b21","first-page":"361","article-title":"Evaluation of melatonin practices for delirium in pediatric critically ill patients","volume":"26","author":"Laudone","year":"2021","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"(7)","key":"2023111414185288400_i2331-348X-28-6-540-b22","article-title":". Melatonin use in infants admitted to intensive care units","volume":"28","author":"Bradford","year":"2023","journal-title":"J Pediatr Pharmacol Ther."},{"issue":"(1)","key":"2023111414185288400_i2331-348X-28-6-540-b23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1177\/000992280204100111","article-title":"The use of haloperidol in agitated critically ill children","volume":"41","author":"Harrison","year":"2002","journal-title":"Clin Pediatr"},{"issue":"(6)","key":"2023111414185288400_i2331-348X-28-6-540-b24","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/01.BCR.0000144540.21272.2C","article-title":"The use of haloperidol and associated complications in the agitated, acutely ill pediatric burn patient","volume":"25","author":"Ratcliff","year":"2004","journal-title":"J Burn Care Rehabil"},{"issue":"(1)","key":"2023111414185288400_i2331-348X-28-6-540-b25","first-page":"87","article-title":"Evaluation of QTc interval effects of antipsychotic medications for intensive care unit delirium in pediatric patients","volume":"26","author":"Hutchins","year":"2021","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"(6)","key":"2023111414185288400_i2331-348X-28-6-540-b26","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00134-007-0637-8","article-title":"Pediatric delirium in critical illness: phenomenology, clinical correlates and treatment response in 40 cases in the pediatric intensive care unit","volume":"33","author":"Schieveld","year":"2007","journal-title":"Intensive Care Med"},{"issue":"(10)","key":"2023111414185288400_i2331-348X-28-6-540-b27","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1007\/s00134-014-3446-x","article-title":"Adverse events of haloperidol for the treatment of delirium in critically ill children","volume":"40","author":"Slooff","year":"2014","journal-title":"Intensive Care Med"},{"issue":"(2)","key":"2023111414185288400_i2331-348X-28-6-540-b28","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.1097\/PCC.0000000000001414","article-title":"Monitoring haloperidol plasma concentration and associated adverse events in critically ill children with delirium: first results of a clinical protocol aimed to monitor efficacy and safety","volume":"19","author":"Slooff","year":"2018","journal-title":"Pediatr Crit Care Med"},{"issue":"(3)","key":"2023111414185288400_i2331-348X-28-6-540-b29","first-page":"204","article-title":"Antipsychotic treatment of delirium in critically ill children: a retrospective matched cohort study","volume":"24","author":"Kishk","year":"2019","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"(2)","key":"2023111414185288400_i2331-348X-28-6-540-b30","first-page":"49","article-title":"Olanzapine reduces delirium symptoms in the critically ill pediatric patient","volume":"2","author":"Sassano-Higgins","year":"2013","journal-title":"J Pediatr Intensive Care"},{"issue":"(5)","key":"2023111414185288400_i2331-348X-28-6-540-b31","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1089\/cap.2013.0001","article-title":"The diagnosis and management of delirium in infancy","volume":"23","author":"Turkel","year":"2013","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"(2)","key":"2023111414185288400_i2331-348X-28-6-540-b32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1089\/cap.2011.0084","article-title":"Atypical antipsychotic medications to control symptoms of delirium in children and adolescents","volume":"22","author":"Turkel","year":"2012","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"(3)","key":"2023111414185288400_i2331-348X-28-6-540-b33","first-page":"121","article-title":"Quetiapine as treatment for delirium in critically ill children: a case series","volume":"2","author":"Traube","year":"2013","journal-title":"Pediatr Intensive Care"},{"issue":"(6)","key":"2023111414185288400_i2331-348X-28-6-540-b34","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/pbc.24917","article-title":"Neuroblastoma and pediatric delirium: a case series","volume":"61","author":"Traube","year":"2014","journal-title":"Pediatr Blood Cancer"},{"issue":"(9)","key":"2023111414185288400_i2331-348X-28-6-540-b35","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1089\/cap.2015.0093","article-title":"Evaluation of the safety of quetiapine in treating delirium in critically ill children: a retrospective review","volume":"25","author":"Joyce","year":"2015","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"(3)","key":"2023111414185288400_i2331-348X-28-6-540-b36","doi-asserted-by":"crossref","first-page":"e20153369","DOI":"10.1542\/peds.2015-3369","article-title":"Detection and management of delirium in the neonatal unit: a case series","volume":"137","author":"Groves","year":"2016","journal-title":"Pediatrics"},{"issue":"(3)","key":"2023111414185288400_i2331-348X-28-6-540-b37","first-page":"271","article-title":"Incidence of corrected QT prolongation with concomitant methadone and atypical antipsychotics in critically ill children","volume":"26","author":"Hughes","year":"2021","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"(5)","key":"2023111414185288400_i2331-348X-28-6-540-b38","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/1060028019891969","article-title":"An evaluation of risperidone dosing for pediatric delirium in children less than or equal to 2 years of age","volume":"54","author":"Campbell","year":"2020","journal-title":"Ann Pharmacother"},{"issue":"(2)","key":"2023111414185288400_i2331-348X-28-6-540-b39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s40272-021-00437-3","article-title":"Haloperidol and quetiapine for the treatment of ICU-associated delirium in a tertiary pediatric ICU: a propensity score-matched cohort study","volume":"23","author":"Cronin","year":"2021","journal-title":"Pediatr Drugs"},{"issue":"(2)","key":"2023111414185288400_i2331-348X-28-6-540-b40","first-page":"596","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes","volume":"27","author":"American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity","year":"2004","journal-title":"Diabetes Care"}],"container-title":["The Journal of Pediatric Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/jppt\/article-pdf\/28\/6\/540\/3288926\/i2331-348x-28-6-540.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/jppt\/article-pdf\/28\/6\/540\/3288926\/i2331-348x-28-6-540.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T13:37:54Z","timestamp":1738762674000},"score":1,"resource":{"primary":{"URL":"https:\/\/jppt.kglmeridian.com\/view\/journals\/jppt\/28\/6\/article-p540.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,1]]},"references-count":40,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,10,28]]},"published-print":{"date-parts":[[2023,10,1]]}},"URL":"https:\/\/doi.org\/10.5863\/1551-6776-28.6.540","relation":{},"ISSN":["2331-348X","1551-6776"],"issn-type":[{"value":"2331-348X","type":"electronic"},{"value":"1551-6776","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,1]]}}}